Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07163845 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT07163845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07163845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil
Lead sponsor
Valneva Austria GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
September 22, 2025
Completion date
December 31, 2026
Enrollment
5,354 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus infection